How many studies have been conducted on Mifepristone?

BiohacksAI has indexed 294 PubMed studies on Mifepristone, including 23 randomized controlled trials (RCTs). 31% of studies involve human subjects.

What are the main research areas for Mifepristone?

The primary research domains for Mifepristone are 🧬 Hormones, 🔬 Oncology, 😴 Sleep. This is based on analysis of 294 PubMed studies using the BiohacksAI evidence platform.

BETABiohacksAI is a research tool for informational purposes only. All outputs are computational hypothesis candidates — not confirmed mechanisms, not medical advice, and not a substitute for professional medical judgment. Independent experimental validation is always required.

Mifepristone

A progestational and glucocorticoid hormone antagonist. Its inhibition of progesterone induces bleeding during the luteal phase and in early pregnancy by releasing endogenous prostaglandins from the endometrium or decidua. As a glucocorticoid receptor antagonist, the drug has been used to treat hypercortisolism in patients with nonpituitary CUSHING SYNDROME.

294+ PubMed studies analyzed · 23 RCTs · Evidence Score: 44.6

Research Domains

Mifepristone has been studied across 17 research domains including 🧬 Hormones, 🔬 Oncology, 😴 Sleep, 🫁 Liver & Detox, 🔬 Inflammation. The primary research focus is 🧬 Hormones with 18% of studies addressing this area.

Loading evidence profile...

This evidence profile for Mifepristone is generated deterministically from 294 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.